Tech Company Financing Transactions
Dascena Funding Round
On 5/1/2020, Dascena received $50 million in Series B investment from Frazier Healthcare Partners, Euclidean Capital and Longitude Capital Management.
Transaction Overview
Company Name
Announced On
5/1/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance a suite of machine learning algorithms to inform patient care strategies and improve outcomes.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
414 13th St. 500
Oakland, CA 94612
USA
Oakland, CA 94612
USA
Phone
Website
Email Address
Overview
Dascena develops algorithms as predictive biomarkers for complex conditions. Dascena was founded in 2015 with a mission to establish statistical algorithms as a new category of diagnostic tools and bring clinical practice to new heights of quality, precision, effectiveness, and affordability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ritankar Das
VP - Bus. Development
Jonathan Roberts
Browse more venture capital transactions:
Prev: 5/1/2020: Merchants Fleet venture capital transaction
Next: 5/1/2020: Vida Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs